Evidence that cytochrome P-4502E1 contributes to ethanol elimination at low doses: Effects of diallyl sulfide and 4-methyl pyrazole on ethanol elimination in the perfused rat liver

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 1 SUPPL., 1996, Pages

  Matsumoto, Hiroshi ^a   Matsubayashi, Keiko ^a   Fukui, Yuko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alcohol Dehydrogenase; Cytochrome P 4502E1; Dispersion Model; Ethanol Elimination; Rat Liver

Indexed keywords

4 METHYLPYRAZOLE; ALCOHOL; ALCOHOL DEHYDROGENASE; ALLYL SULFIDE; CYTOCHROME P450;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DEHYDROGENASE; ALLYL COMPOUNDS; ANIMALS; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; LIVER; MALE; METABOLIC CLEARANCE RATE; MODELS, THEORETICAL; OXIDOREDUCTASES, N-DEMETHYLATING; PERFUSION; PYRAZOLES; RATS; RATS, WISTAR; SULFIDES;

EID: 0029990040     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01719.x     Document Type: Article

References (25)

1. Lieber CS: Mechanisms of ethanol-drug-nutrition interactions. J Toxicol Clin Toxicol 32:631-681, 1994
2. Fujimiya T, Yamaoka K, Fukui Y: Parallel first-order and Michaelis-Menten elimination kinetics of ethanol. Respective role of alcohol dehydrogenase (ADH), non-ADH and first-order pathways. J Pharmacol Exp Ther 249:311-317, 1989
3. Matsumoto H, Fujimiya T, Fukui Y: Role of alcohol dehydrogenase in rat ethanol elimination kinetics. Alcohol Alcohol 29:15-20, 1994
4. Damgaard SE: The D(V/K) isotope effect of the cytochrome P450-mediated oxidation of ethanol and its biological applications. Eur J Biochem 125:593-603, 1982
5. Clejan LA, Cederbaum AI: Oxidation of pyrazole by reconstituted systems containing cytochrome P-450 IIE1. Biochem Biophys Acta 1034:233-237, 1990
6. Chow HH, Hutchaleclaha A, Mayersohn M: Inhibitory effect of 4-methylpyrazole on antipyrine clearance in rats. Life Sci 50:661-666, 1992
7. Brady JF, Li D, Ishizaki H, Yang CS: Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res 48:5937-5940, 1988
8. Brady JF, Wang MH, Hong JY, Xiao F, Li Y, Yoo JH, Ning SM, Lee M, Fukuto JM, Gapac JM, Yang CS: Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide. Toxicol Appl Pharmacol 108:342-354, 1991
9. Bradford BU, Forman DT, Thurman RG: 4-Methyl pyrazole inhibits fatty acyl coenzyme synthetase and diminishes catalase-dependent alcohol metabolism: Has the contribution of alcohol dehydrogenase to alcohol metabolism been previously overestimated? Mol Pharmacol 43:115-119, 1993
10. Keiding S, Priisholm K: Current models of hepatic pharmacokinetics: Flow effects on kinetic constants of ethanol elimination in perfused rat liver. Biochem Pharmacol 33:3209-3212, 1984
11. Greenway CV: Effects of hepatic blood flow on hepatic ethanol kinetics measured in cats and predicted from the parallel tube model. Can J Physiol Pharmacol 67:728-733, 1989
12. Matsumoto H, Matsubayashi K, Fukui Y: Estimation of ethanol first-pass effect in the perfused rat liver. Alcohol Alcohol 29:9-13, 1994
13. Roberts MS, Rowland M: A dispersion model of hepatic elimination. 1. Formulation of the model and bolus considerations. J Pharmacokinet Biopharm 14:227-260, 1986
14. Yano Y, Yamaoka K, Aoyama Y, Tanaka H: Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT). J Pharmacokinet Biopharm 17:179-202, 1989
15. Hijioka T, Sato N, Matsumura H, Yoshihara Y, Takei H, Fukui H, Oshita S, Kawano S, Kamada T: Ethanol-induced disturbance of hepatic microcirculation and hepatic hypoxia. Biochem Pharmacol 41:1551-1557, 1989
16. Oshita S, Takei Y, Kawano S, Yoshioka H, Hijioka T, Fukui H, Goto M, Masuda E, Nishimura Y, Fusamoto H, Kamada T: Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest 91:1337-1342, 1993
17. Yamaoka K, Nakagawa T, Uno T: Statistical moments in pharmacokinetics. J Pharamcokinet Biopharm 6:547-558, 1978
18. Huet PM, Kassissia I, Semret M: Haemodynamics in perfused rat liver, in Ballet F, Thurman RG (eds): Research in Perfused Liver. London, John Libbey/INSERM, 1991
19. Leiber CS: Alcohol and the liver: 1994 Update. Gasteroenterology 106:1085-1105, 1994
20. Teorell H, Yonetani T: Liver alcohol dehydrogenase-DPN-pyrazole complex: A model of a ternary intermediate in the enzyme reaction: Biochem Z 338:537-553, 1963
21. Evans AM, Hussein Z, Rowland M: A two-compartment dispersion model describes the hepatic outflow profiles of diclofenac in the presence of its binding protein. J Pharm Pharmacol 43:709-714, 1991
22. Pang KS, Xu X, Morris ME, Yuen V: Kinetics modeling of conjugations in liver. Fed Proc 46:2439-2441, 1987
23. Ingelman-Sundberg M, Johansson I, Penttila KE, Glauman H, Lindros KO: Centrilobular expression of ethanol-inducible cytochrome P450 (IIE1) in rat liver. Biochem Biophys Res Commum 157:55-60, 1988
24. Tsutsumi M, Lasker JM, Shimizu M, Kitada M, Lieber CS: The intralobular distribution of ethanol-inducible P450 IIE1 in rat and human liver. Hepatology 10:437-446, 1989
25. Takada A: Alcoholic liver disease: Its classification and pathogenesis, in Kuriyama K, Takada A, Ishii H (eds): Biomedical and Social Aspects of Alcohol and Alcoholism. Amsterdam, Elsevier Science Publishers B.V., 1988, pp 9-16